3, 4 and 5
Studies show that A. squamosa L. and its active principals possess wide pharmacological actions including antidiabetic, antioxidative, antirheumatic, antilipidemic NVP-BGJ398 datasheet and insecticide. 6, 7, 8, 9 and 10 A fraction of total alkaloid from roots exhibits antihypertensive, antispasmodic, antihistaminic and bronchodilator properties. Leaves contain cardiotonic alkaloids, quinoline, squamone, and bullatacinone were selectively cytotoxic to human breast carcinoma. Two new compounds have been isolated & are reported in this paper which are 5-((6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)-2-methoxybenzene-1,3-diol and (1R,3S)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline-1,3-diol. These compounds are found to be antiulcer in nature. The isolated compounds were evaluated for their activity on Hydrogen Potassium ATPase enzyme and were compared with the omeprazole as the standard drug. Activity was found to be quite comparable. All chemicals used were of analytical grade. Twigs of A. squamosa PFT�� molecular weight (6.0 Kg) were shade dried and finely powdered and placed for maceration with ethanol (18 L) and were kept at room temperature for 48 h. The macerated material was collected. This process of extraction was repeated for five times, till the plant material was extracted exhaustively. The total extract concentrated at 40–45 °C
and weighed. The extract weighed 520 g (8.66%). Ethanolic
extract (500 g) was taken and triturated with n-hexane (250 ml × 15), the hexane fraction concentrated under low pressure at 40 °C. After trituration with hexane the residue was triturated with chloroform until (250 ml × 15), chloroform soluble fraction was evaporated under low pressure; weight of fraction obtained 95 g. After trituration with chloroform, residue was then kept in distilled water (2 L) and then it was fractionated with Aq. saturated n-butanol (500 ml × 10). This fraction was concentrated low pressure at 50 °C (15 g). Aqueous fraction also concentrated under low pressure at 45–50 °C (20 g). Repeated column chromatography was done on chloroform fraction in order to isolate the two new compounds viz. 5-((6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)-2-methoxybenzene-1,3-diol and (1R,3S)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline-1,3-diol. Melting point for compound no.1 is 194–196 °C, molecular formula is C20H25NO5, m/z obtained at 360.17. Compound no.2 which is characterized as (1R,3S)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline-1,3-diol has a melting point range of 124–126 °C, molecular formula is C12H17NO4, m/z obtained at 240.13. The chloroform fraction (95.0 g) was chromatographed on silica gel (60–120 mesh, 900 g), using hexane with increasing amount of chloroform and methanol as eluent.